Strategies for the Discovery and Design of Tissue Plasminogen Activators: Insights Into Bioengineering Objectives Publisher Pubmed



Arsanjani AA¹ ; Faradonbeh DR¹ ; Malekshahi ZV¹ ; Mosayyebi B¹ ; Negahdari B¹ Show Affiliations
Source: Drug Development Research Published:2025

Abstract

Tissue plasminogen activators (tPAs) are critical in fibrinolysis and have become central to treating thrombotic disorders, including heart attacks, strokes, and pulmonary embolisms. Despite their efficacy, challenges such as bleeding complications, limited fibrin specificity, and rapid clearance necessitate the discovery of novel tPAs and the engineering of improved variants. This review highlights strategies for the discovery of tPAs from natural sources, including human, bacterial, venom-derived, and bat saliva-derived agents, as well as enzyme engineering approaches that enhance functional characteristics such as half-life, fibrin specificity, resistance to inhibitors, and clot penetration. Furthermore, this review explores alternative therapeutic approaches independent of tPAs, focusing on nonplasminogen activator agents and strategies that target platelets. By addressing current challenges and identifying future opportunities, this review provides a comprehensive perspective on advancing thrombolytic therapies through innovative discovery and design strategies. © 2025 Wiley Periodicals LLC.